Tissue therapies posts small loss

By Renate Krelle
Thursday, 10 February, 2005

Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.

At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.

It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.

An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...

A cancer drug currently being tested in patients appears to have entered clinical trials based on...

Russian health authorities say there is no evidence that pneumonic plague played a part in the...

Content from other channels on our network

The roles of the vendor and EPCs in the project bidding process

ARC awards $82.5m for new research hubs and training centres

Industrial electricity costs could halve by sharing infrastructure

Seeq and Applied Computing partner on industrial AI for energy operations

ARENA opens Round 3 of Solar Sunshot with $250m available

AFGC welcomes Domestic Gas Reservation Bill

Beverage facility built to keep the good times rolling

Industries transitioning away from gas, A2EP report released

Six on the shelf: from frozen treats to smoothies & meal kits

58% of food manufacturers report less productivity, research finds

Burnout in health care isn't an 80/20 problem: why a more balanced view is needed and what it means for you and your workplace

A Good Cleaning Schedule: Best Practices for Healthcare Facilities

Conviction and $20K fine follows "serious and prolonged" offending by former podiatrist

Supagas acquires Heeson Medical

Why digital resilience is becoming critical in aged care